Want to see SE:NNH full AI Analyst Report?
NNH Stock Chart & Stats
kr12.35
kr0.00(0.00%)
At close: 4:00 PM EDT
kr12.35
kr0.00(0.00%)
Day’s Range― - ―
52-Week Rangekr11.60 - kr27.70
Previous CloseN/A
Volume1.66K
Average Volume (3M)5.45K
Market Cap
kr127.62M
Enterprise Valuekr102.11
Total Cash (Recent Filing)kr9.91M
Total Debt (Recent Filing)kr37.06M
Price to Earnings (P/E)47.9
Beta0.48
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.21%
Share Statistics
EPS (TTM)N/A
Shares Outstanding6,195,200
10 Day Avg. Volume3,153
30 Day Avg. Volume5,451
Financial Highlights & Ratios
PEG Ratio-0.09
Price to Book (P/B)1.39
Price to Sales (P/S)0.25
P/FCF Ratio18.98
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
International Brand And DistributionA multi-country branded presence and diversified retail/pharmacy distribution reduces single-market dependence and supports steady revenue lines. The branded, natural/herbal positioning aids customer loyalty and repeat purchases, providing a durable revenue foundation across markets.
Return To Profitability With Modest Top-line GrowthReaching positive EBIT and net income on a trailing-twelve-month basis with continued revenue growth indicates operational recovery. This rebuild of profitability and revenue momentum strengthens internal funding capacity and improves resilience versus prior loss years, aiding medium-term stability.
Manageable Leverage And Improving ROEModerate debt (around one-third of equity) and a return to positive ROE provide balance-sheet flexibility and reduced refinancing strain. A solid equity base relative to assets gives capacity to absorb shocks and fund operations without aggressive external financing, supporting durable financial stability.
Bears Say
Thin Margins Limit Downside AbsorptionVery narrow net and operating margins mean small cost increases, pricing pressure, or adverse channel mix can eliminate profits. Thin margins limit reinvestment and buffer capacity, making earnings sensitive to minor demand or cost swings and reducing durability of profitability over months.
Cash Generation Small And UnevenWhile FCF improved and roughly tracks net income, absolute operating cash is small versus business scale and historically uneven. Prior years saw negative operating/free cash flow, meaning limited internal funding for growth or shocks and greater reliance on disciplined working-capital management.
Historic Volatility And Execution DependenceMaterial swings from profit to loss show the business is execution-sensitive. Periodic volatility in results and asset growth outpacing equity at times increases reliance on consistent management execution and stable margins; failure to sustain execution risks erosion of the recent recovery.
NNH FAQ
What was New Nordic Healthbrands AB’s price range in the past 12 months?
New Nordic Healthbrands AB lowest stock price was kr11.60 and its highest was kr27.70 in the past 12 months.
What is New Nordic Healthbrands AB’s market cap?
New Nordic Healthbrands AB’s market cap is kr127.62M.
When is New Nordic Healthbrands AB’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were New Nordic Healthbrands AB’s earnings last quarter?
Currently, no data Available
Is New Nordic Healthbrands AB overvalued?
According to Wall Street analysts New Nordic Healthbrands AB’s price is currently Overvalued.
Does New Nordic Healthbrands AB pay dividends?
New Nordic Healthbrands AB pays a Notavailable dividend of kr0.25 which represents an annual dividend yield of 1.21%. See more information on New Nordic Healthbrands AB dividends here
What is New Nordic Healthbrands AB’s EPS estimate?
New Nordic Healthbrands AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does New Nordic Healthbrands AB have?
New Nordic Healthbrands AB has 6,195,200 shares outstanding.
What happened to New Nordic Healthbrands AB’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of New Nordic Healthbrands AB?
Currently, no hedge funds are holding shares in SE:NNH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
New Nordic Healthbrands AB
New Nordic Healthbrands AB (NNH) is a Swedish company operating in the health and wellness sector, focused on developing, marketing, and distributing branded dietary supplements and related health products. The company’s offerings are positioned around “natural” or “herbal” formulations and are sold under the New Nordic brand in multiple international markets through retail and pharmacy channels as well as other distribution partners.
Technical Analysis
Midsona AB Class B
―
Humble Group AB
―
Skane-moellan AB
―
Cheffelo AB
―
Premium Snacks Nordic AB
―